Follow
Jianying XU
Jianying XU
Verified email at campus.lmu.de
Title
Cited by
Cited by
Year
Current status and advances of immunotherapy in nasopharyngeal carcinoma
JY Xu, XL Wei, YQ Wang, FH Wang
Therapeutic Advances in Medical Oncology 14, 17588359221096214, 2022
312022
Association of plasma Epstein-Barr virus DNA with outcomes for patients with recurrent or metastatic nasopharyngeal carcinoma receiving anti–programmed cell death 1 immunotherapy
JY Xu, XL Wei, C Ren, Y Zhang, YF Hu, JY Li, JL Chen, YQ Wang, F Han, ...
JAMA Network Open 5 (3), e220587-e220587, 2022
262022
Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer
XL Wei, JY Xu, DS Wang, DL Chen, C Ren, JN Li, F Wang, FH Wang, ...
Therapeutic advances in medical oncology 13, 1758835921988996, 2021
232021
The impact of mismatch repair status on prognosis of patients with gastric cancer: a multicenter analysis
WL Guan, Y Ma, YH Cui, TS Liu, YQ Zhang, ZW Zhou, JY Xu, LQ Yang, ...
Frontiers in oncology 11, 712760, 2021
202021
Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature
JY Xu, WL Guan, SX Lu, XL Wei, WJ Shi, C Ren, YH Li, SP Li, MZ Qiu, ...
Clinical Medicine Insights: Oncology 16, 11795549221090186, 2022
102022
ClC‐3 chloride channels are involved in estradiol regulation of bone formation by MC3T3‐E1 osteoblasts
Z Deng, W Li, J Xu, M Yu, D Li, Q Tan, D Wang, L Chen, L Wang
Journal of Cellular Biochemistry 120 (5), 8366-8375, 2019
102019
Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians
J Wang, J Zhuge, D Feng, B Zhang, J Xu, D Zhao, Z Fei, X Huang, W Shi
BMC cancer 22 (1), 273, 2022
52022
The system can't perform the operation now. Try again later.
Articles 1–7